Fernando Varela - Raia Drogasil Executive
| RADLY Stock | USD 3.74 0.54 12.62% |
Executive
Mr. Fernando Kozel Varela serves as the Chief of Technology, Supply Chain and Omnichannel of Raia Drogasil SA since November 10, 2011. He has 18 years experience in the Company. He initiated his career at Arthur Andersen. In 1996, he joined Raia SA as Projects Manager. Since 2002, he was its Chief Operating Officer. He graduated in Electrical Engineering from Universidade de Sao Paulo and gained a Masters of Business Administration from the University of Pittsburgh. since 2011.
| Age | 47 |
| Tenure | 13 years |
| Phone | 55 11 3769 5678 |
| Web | https://www.rd.com.br |
Raia Drogasil Management Efficiency
The company has return on total asset (ROA) of 0.0667 % which means that it generated a profit of $0.0667 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1825 %, meaning that it generated $0.1825 on every $100 dollars invested by stockholders. Raia Drogasil's management efficiency ratios could be used to measure how well Raia Drogasil manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| CPA CMA | High Tide | N/A | |
| Wendy Zalai | PetMed Express | N/A | |
| Caroline Conegliano | PetMed Express | N/A | |
| Joseph Amsbary | Walgreens Boots Alliance | N/A | |
| Omar Khan | High Tide | N/A | |
| Aidan Clare | Walgreens Boots Alliance | N/A | |
| Sandy Sharma | High Tide | N/A | |
| Liyue Wu | Walgreens Boots Alliance | N/A | |
| Nicole Sanchez | Leafly Holdings | N/A | |
| Ming Zhao | China Jo Jo Drugstores | 48 | |
| Yan Liu | China Jo Jo Drugstores | 34 | |
| Lanesha Minnix | Walgreens Boots Alliance | 49 | |
| Theresa Mota | SunLink Health Systems | N/A | |
| Robyn DElia | PetMed Express | N/A | |
| Lanesha JD | Walgreens Boots Alliance | 49 | |
| Tiffany Kanaga | Walgreens Boots Alliance | N/A | |
| Jacqueline Smith | PetMed Express | N/A | |
| John Driscoll | Walgreens Boots Alliance | 65 | |
| Elizabeth Burger | Walgreens Boots Alliance | 53 | |
| Carla Dodds | PetMed Express | N/A | |
| Umesh Sripad | PetMed Express | N/A | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0667 |
Raia Drogasil SA Leadership Team
Elected by the shareholders, the Raia Drogasil's board of directors comprises two types of representatives: Raia Drogasil inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Raia. The board's role is to monitor Raia Drogasil's management team and ensure that shareholders' interests are well served. Raia Drogasil's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Raia Drogasil's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eugnio Zagottis, IR, Planning | ||
| Antonio Coelho, CFO, Member of the Executive Board | ||
| Ligia Mendes, Controllership charge | ||
| Fernando Varela, Chief Technology and Logistics Officer, Member of the Executive Board | ||
| Maria Souza, Director of Human Resources, Member of the Executive Board | ||
| Gabriel Rozenberg, IR Director | ||
| Renato Raduan, Director of Retail Operations, Member of the Executive Board | ||
| Bruno Pipponzi, VP Board | ||
| Marcello Zagottis, Chief Marketing, Sales and Commercial Officer, Member of the Executive Board | ||
| Marclio Pousada, CEO Board |
Raia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Raia Drogasil a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0667 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 8.48 B | |||
| Shares Outstanding | 1.65 B | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | 80.00 X | |||
| Price To Book | 7.21 X | |||
| Price To Sales | 0.26 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Raia Pink Sheet Analysis
When running Raia Drogasil's price analysis, check to measure Raia Drogasil's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raia Drogasil is operating at the current time. Most of Raia Drogasil's value examination focuses on studying past and present price action to predict the probability of Raia Drogasil's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raia Drogasil's price. Additionally, you may evaluate how the addition of Raia Drogasil to your portfolios can decrease your overall portfolio volatility.